| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Amyotrophic lateral sclerosis | 2 | 1 | |
| Multiple sclerosis | 2 | 0 | |
| Acne | 1 | 1 | |
| Inflammation | 1 | 0 | |
| Lyme disease | 1 | 1 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Hyperpigmentation (skin darkening) | 1 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 2 | |
| Mild | 1 | |
| None | 2 |